Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: ST612 MRSA in Western Australia

PROVIDER: PRJNA558684 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	VRNI01.dat.gz	Other
	VRNI01.fasta.gz	Fasta.gz
	VRNI01.master.dat	Other
	VRNJ01.dat.gz	Other

Items per page:

1 - 5 of 151

Similar Datasets

Project description:Western Australia Salmonella typhimurium

| PRJNA597822 | ENA

Western Australia soil biocrust

Project description:Western Australia soil biocrust

| PRJEB30054 | ENA

Ptilotus macrocephalus isolate:Australia (Western Australia)

Project description:Ptilotus macrocephalus isolate:Australia (Western Australia) Genome sequencing

| PRJNA494463 | ENA

Project description:Microbat faecal virome - Western Australia

| PRJNA646531 | ENA

Metabolomics of Shark Bay stromatolites

Project description:microbial mats were collected from Shark Bay, Western Australia and we want to compare two mat types from this site.

2017-01-11 | ST000572 | MetabolomicsWorkbench

Project description:Metatranscriptomics of Drosophila simulans in Western Australia

| PRJNA706433 | ENA

Project description:Virome of Culex annulirostris from Western Australia

| PRJNA632594 | ENA

Proteomic analysis of anti-MRSA activity of caerin 1.1/1.9 in a murine skin infection model

Project description:Caerin 1 is a family of host-defense peptides with antimicrobial property originally isolated from Australia tree frog. Caerin 1.1+1.9 has been shown to inhibit multiple antibiotic resistant bacteria infection both in vitro and in vivo. In current study, we compare the MICs of caerin 1.1/1.9 with commonly used antibiotics against S. aureus, Copper-Green Pseudomonas aeruginosa, Acinetobacter baumannii, and Streptococcus haemolyticus. We demonstrate that caerin 1.1/1.9 not only prevent the formation of biofilm by A. Baumann, but also have therapeutic effect on established biofilm. In addition, we find that caerin1.1/1.9 significantly inhibit the growth of methicillin-resistant Staphylococcus aureus (MRSA) strain in a murine skin infection model. The quantitative proteomic analysis suggested that caerin1.1/1.9 largely activate oxidative phosphorylation, as well as several pathways associated with tissue repair and growth, with respect to the untreated tissues infected with MRSA in mice. In summary, our results suggest that caerin 1.1/1.9 have the potential to be used as a drug candidate treating complicated antibiotic resistant bacterial infection in human.

2023-10-11 | PXD044425 | Pride

Project description:Magnetite Fe ore tailing rehabilitation in Western Australia

| PRJNA552777 | ENA

Cherax

Project description:Cherax spp. from western Australia Raw sequence reads

| PRJNA977459 | ENA